Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes

Vaccine

Volumn 18, Issue 15, 2000, Pages 1506-1514

  Hasan, U A ^a   Harper, D R ^a   Argent, S ^a   Layton, G ^b   Wren, B W ^a   Morrow, W J W ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Chickenpox; Human herpes virus 3; Nucleic acid immunization; Shingles

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; IMMUNOGLOBULIN G2A;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; CELLULAR IMMUNITY; CONFERENCE PAPER; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TH1 CELL; VARICELLA ZOSTER VIRUS;

ANIMALS; ANTIBODIES, VIRAL; HERPESVIRUS 3, HUMAN; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0033962046     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00428-4     Document Type: Conference Paper

References (23)

1. Hasan UA, Abai A, Harper DR, Wren BW, Morrow WJW. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J Immunol Methods 1999;229:1.
2. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1986;1759.
3. Davison A.J. Varicella-zoster virus. J. Gen. Virol. 72:1991;475.
4. Cohen J.I., Straus S.E. Varicella-zoster virus and its replication. Fields B.N., Knipe D.M., Howley P.M. Fields virology. 1996;2525 Raven Publishers, Philadelphia.
5. Davison A.J., Edson C.M., Ellis R.W., Forgani B., Gilden D., Grose C., Keller P.M., Vafai A., Wroblewaska Z., Yamanishi K. New common nomenclature for glycoproteins genes of varicella-zoster virus and there glycosylated products. J. Virol. 57:1986;1195.
6. Garcia-Valcarcel M., Fowler W.J., Harper D.R., Jeffries D.J., Layton G.T. Induction of neutralising antibody and T cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE). Vaccine. 15:1997;709.
7. Sambrook J., Fritsch E.F., Maniatis T. Transfection. Molecular cloning: a laboratory manual. 2nd ed. 1989;16.33.
8. Harper D.R., Kangro H.O., Heath R.B. Antibody responses in recipients of varicella vaccine assayed by immunoblotting. J. Med. Virol. 30:1990;61.
9. Harper D.R., Kangro H.O., Heath R.B. Serological responses in varicella and zoster assayed by immunoblotting. J. Med. Virol. 25:1988;387.
10. Nass P., Elkins K., Weir J. Antibody responses and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins. J. Inf. Dis. 178:1998;611.
11. Kriesel J., Sprunace S., Daynes R., Araneo B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Inf. Dis. 173:1996;536.
12. Arvin A.M. Varicella-zoster virus. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;2547 Raven Publishers, Philadelphia.
13. Mo C., Suen J., Sommer M., Arvin A.M. Characterization of varicella zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol. 73:1999;4197.
14. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B cell activation. Nature. 374:1995;546.
15. Fynan E.F., Robinson H.L., Webster R.G. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell. Biol. 12:1993;785.
16. Ulmer J.B., Deck R.R., DeWitt C.M., Donnelly J.J., Friedman A., Montgomery D.L., Yawman A.M., Orme I.M., Denis O., Content J., et al. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Behring Inst. Mitt. 98:1997;79.
17. Lowrie D.B., Silva C.L., Colston M.J., Ragno S., Tascon R.E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine. 15:1997;834.
18. Doolan D.L., Hedstrom R.C., Gardner M.J., Sedegah M., Wang H., Gramzinski R.A., Margalith M., Hobart P., Hoffman S.L. DNA vaccination as an approach to malaria control: current status and strategies. Curr. Top. Microbiol. Immunol. 226:1998;37.
19. Manoutcharian K., Terrazas L.I., Gevorkian G., Govezensky T. Protection against murine cysticercosis using cDNA expression library immunization. Immunol. Lett. 62:1998;131.
20. Waine G.J., Yang W., Scott J.C., McManus D.P., Kalinna B.H. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes. Vaccine. 15:1997;846.
21. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1998;1320.
22. Power C.A., Wei G., Bretscher P.A. Mycobacteria dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by intravenous, subcutaneous, or intradermal route. Infect. Immun. 66:1998;5743.
23. Golbatt D. The immunology of chickenpox. J. Infect. 36:(Suppl. 1):1998;11.